Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 4,122 | 3,551 | 3,329 | 3,465 | 2,567 |
| Cost of Goods | 2,122 | 1,873 | 1,643 | 1,824 | 1,358 |
| Gross Profit | 2,000 | 1,678 | 1,686 | 1,641 | 1,209 |
| Operating Expenses | 6,570 | 6,987 | 5,983 | 5,694 | 5,804 |
| Operating Income | -4,448 | -4,436 | -3,654 | -3,229 | -4,237 |
| Interest Expense | 112 | 66 | 34 | 29 | 27 |
| Other Income | 171 | 1,324 | -616 | 280 | -356 |
| Pre-tax Income | -4,389 | -3,178 | -4,304 | -2,978 | -4,620 |
| Net Income Continuous | -4,389 | -3,178 | -4,304 | -2,978 | -4,620 |
| Net Income | $-4,389 | $-3,178 | $-4,304 | $-2,978 | $-4,620 |
| EPS Basic Total Ops | -4.95 | -3.60 | -4.95 | -3.45 | -5.40 |
| EPS Basic Continuous Ops | -4.95 | -3.60 | -4.94 | -3.47 | -5.44 |
| EPS Diluted Total Ops | -4.95 | -3.60 | -4.95 | -3.45 | -5.40 |
| EPS Diluted Continuous Ops | -4.95 | -3.60 | -4.94 | -3.47 | -5.44 |
| EBITDA(a) | $-4,034 | $-4,181 | $-3,486 | $-2,996 | $-4,006 |